Vaccination saves lives: How do patients with chronic diseases and severe COVID-19 fare? Analysis from India’s National Clinical registry for COVID-19
Preprint
Abstract
Objectives: This study aims to describe the demographic and clinical profile and ascertain the determinants of outcome among hospitalised COVID-19 adult patients enrolled in the National Clinical Registry for COVID-19 (NCRC). Methods: NCRC is an on-going data collection platform operational in 42 hospitals across India. Data of hospitalized COVID-19 patients enrolled in NCRC between 1 st September 2020 to 26 th October 2021 were examined. Results: Analysis of 29,509 hospitalised, adult COVID-19 patients [mean (SD) age: 51.1 (16.2) year; male: 18752 (63.6%)] showed that 15678 (53.1%) had at least one comorbidity. Among 25715 (87.1%) symptomatic patients, fever was the commonest symptom (72.3%) followed by shortness of breath (48.9%) and dry cough (45.5%). In-hospital mortality was 14.5% (n=3957). Adjusted odds of dying were significantly higher in age-group ≥60 years, males, with diabetes, chronic kidney diseases, chronic liver disease, malignancy, and tuberculosis, presenting with dyspnea and neurological symptoms. WHO ordinal scale 4 or above at admission carried the highest odds of dying [5.6 (95% CI: 4.6, 7.0)]. Patients receiving one [OR: 0.5 (95% CI: 0.4, 0.7)] or two doses of anti-SARS CoV-2 vaccine [OR: 0.4 (95% CI: 0.3, 0.7)] were protected from in-hospital mortality. Conclusions: WHO ordinal scale at admission is the most important independent predictor for in-hospital death in COVID-19 patients. Anti-SARS-CoV2 vaccination provides significant protection against mortality.Keywords
This publication has 16 references indexed in Scilit:
- Prevalence and predictors of in-hospital mortality of patients hospitalized with COVID-19 infectionJournal of Infection and Public Health, 2021
- COVID-19 and liver disease: mechanistic and clinical perspectivesNature Reviews Gastroenterology & Hepatology, 2021
- Impact of chronic liver disease upon admission on COVID-19 in-hospital mortality: Findings from COVOCA studyPLOS ONE, 2020
- Risk Factors Associated With In-Hospital Mortality in a US National Sample of Patients With COVID-19JAMA Network Open, 2020
- Clinical profile and predictors of in-hospital mortality among older patients hospitalised for COVID-19Age and Ageing, 2020
- Age-specific mortality and immunity patterns of SARS-CoV-2Nature, 2020
- High rates of 30-day mortality in patients with cirrhosis and COVID-19Journal of Hepatology, 2020
- Association between tuberculosis and COVID‐19 severity and mortality: A rapid systematic review and meta‐analysisJournal of Medical Virology, 2020
- Epidemiological determinants of COVID-19 infection and mortality: A study among patients presenting with severe acute respiratory illness during the pandemic in Bihar, IndiaNigerian Postgraduate Medical Journal, 2020
- Prevalence of diabetes and prediabetes in 15 states of India: results from the ICMR–INDIAB population-based cross-sectional studyThe Lancet Diabetes & Endocrinology, 2017